FDA Goes After Unapproved Eye Washes, Skin Ointments (MedicineNet.com)
Title: FDA Goes After Unapproved Eye Washes, Skin Ointments Category: Health News Created: 9/24/2008 2:00:00 AM Last Editorial Review: 9/24/2008

Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward ... (PR Newswire via Yahoo! Finance)
Anthera Pharmaceuticals announced today they have reached agreement with the U.S. Food and Drug Administration on a Phase 3 protocol for varespladib in acute coronary syndrome under the FDA's Special Protocol Assessment procedure.